Detalhe da pesquisa
1.
Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments.
J Magn Reson Imaging;
2023 Oct 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37787109
2.
Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross-sectional analysis from the MS-STAT2 randomized controlled trial.
Eur J Neurol;
30(9): 2769-2780, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37318885
3.
Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: Analysis from the MS-STAT randomised controlled trial.
Mult Scler;
28(12): 1913-1926, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35946107
4.
Plasma melatonin is reduced in Huntington's disease.
Mov Disord;
29(12): 1511-5, 2014 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25164424
5.
A Systematic Review of Resting-State Functional MRI Connectivity Changes and Cognitive Impairment in Multiple Sclerosis.
Brain Connect;
12(2): 112-133, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34382408
6.
Optimising recruitment in clinical trials for progressive multiple sclerosis: observational analysis from the MS-SMART and MS-STAT2 randomised controlled trials.
Trials;
23(1): 644, 2022 Aug 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35945550
7.
Association of Slowly Expanding Lesions on MRI With Disability in People With Secondary Progressive Multiple Sclerosis.
Neurology;
98(17): e1783-e1793, 2022 04 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35277438
8.
Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial.
Lancet Neurol;
19(3): 214-225, 2020 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31981516
9.
Sex effects across the lifespan in women with multiple sclerosis.
Ther Adv Neurol Disord;
13: 1756286420936166, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32655689
10.
Just a graze? Cephalic tetanus presenting as a stroke mimic.
Pract Neurol;
14(1): 39-41, 2014 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24052566
11.
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis.
BMJ Open;
8(8): e021944, 2018 08 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30166303
12.
Multiple sclerosis, a treatable disease .
Clin Med (Lond);
17(6): 530-536, 2017 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29196354
13.
Multiple sclerosis, a treatable disease.
Clin Med (Lond);
16(Suppl 6): s53-s59, 2016 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27956442
14.
Secondary Progressive Multiple Sclerosis: Definition and Measurement.
CNS Drugs;
30(6): 517-26, 2016 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27166830
15.
MS-SMART study: systematic sampling bias concerns - Authors' reply.
Lancet Neurol;
19(6): 479-480, 2020 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32470412
16.
Increasing awareness of eGFR monitoring.
Br J Psychiatry;
194(2): 191, 2009 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19182201
17.
An unusual bump on the head. Intraextracranial meningioma presenting incidentally.
BMJ Case Rep;
20122012 Jun 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22744251
18.
Dimethyl fumarate may still have a role in progressive multiple sclerosis.
Ther Adv Neurol Disord;
9(4): 344-5, 2016 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27366242